Cangrelor Tetrasodium CAS 163706-36-3 Purity >98.5% (HPLC)

Short Description:

Chemical Name: Cangrelor Tetrasodium

Synonyms: AR-C 69931 Tetrasodium Salt 

CAS: 163706-36-3

Purity: >98.5% (HPLC)

Appearance: White to Beige Powder 

Antiplatelet Agent, High Quality

Contact: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401


Product Detail

Related Products

Product Tags

163706-36-3 - Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of Cangrelor Tetrasodium (CAS: 163706-36-3) with high quality. Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Cangrelor Tetrasodium, Please contact:

Intermediates of Cangrelor:

163706-36-3 - Chemical Properties:

Chemical Name Cangrelor Tetrasodium  
Synonyms Cangrelor Tetrasodium Salt; AR-C 69931 Tetrasodium Salt; AR-C69931MX Tetrasodium Salt; N-[2-(Methylthio)ethyl]-2-[(3,3,3-Trifluoropropyl)thio] adenosine-5'-O-(β,γ-Dichloromethylene)triphosphate Tetrasodium Salt; N-[2-(Methylthio)ethyl]-2-[(3,3,3-Trifluoropropyl)thio]-,anhydride with P,P′-(Dichloromethylene)bis[phosphonic acid]-5′-Adenylic Acid Tetrasodium Salt
Stock Status In Stock, Commercial Production  
CAS Number 163706-36-3
Molecular Formula C17H21Cl2F3N5O12P3S2·Na4
Molecular Weight 864.29 
Sensitive Light Sensitive, Moisture Sensitive
Water Solubility  H2O: 2 mg/mL, Clear  
COA & MSDS Available
Origin Shanghai, China
Brand Ruifu Chemical

163706-36-3 - Specifications:

Items Specifications 
Appearance White to Beige Powder 
Purity / Analysis Method >98.5% (HPLC) 
Water by Karl Fischer  <13.50%
Sodium (Na)  10.32~10.96%
1H NMR Spectrum Consistent with Structure
LC-MS Consistent with Structure
Conclusion The product has been tested and complies with the given specifications

163706-36-3 - Disclaimer: 

None of the products will be supplied to countries in which this could be in conflict with the existing patents. However the final responsibility lies with the Buyer. 


Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry (2~8℃) and well-ventilated warehouse away from incompatible substances. Protect from light and moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery. 


Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system


How to Purchase? Please contact Dr. Alvin Huang: or 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory AuditFactory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

TransportationBy Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom SynthesisCan provide custom synthesis services to best fit your research needs.

Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

163706-36-3 - Application:

Cangrelor Tetrasodium (CAS: 163706-36-3) is a direct purinergic platelet receptor (P2Y12) inhibitor that blocks ADP-induced platelet activation and aggregation. The drug, which was developed by The Medicine Company, binds reversibly to the P2Y12 receptor, preventing further signaling and platelet activation. Cangrelor, which was approved in June 2015 by the FDA, is indicated as an adjunct to percutaneous coronary intervention for reducing the risk of periprocedural myocardial infarction, repeat coronary revascularization, and stent thrombosis in patients who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor. The most common side effect observed with the drug was bleeding.
Cangrelor is a recently approved intravenous P2Y12 antagonist with a rapid onset of action (2–3 minutes) and recovery of platelet function after discontinuation. In the CHAMPION-PHOENIX trial, compared with patients treated with oral clopidogrel at the time of or immediately after PCI, cangrelor-treated patients had a lower risk of recurrent MI or stent thrombosis at the cost of an increase in minor but not major bleeding. As a result, in patients who were not adequately pretreated with clopidogrel prior to PCI, cangrelor may provide sufficient platelet inhibition to conduct PCI safely. 

  • Write your message here and send it to us